Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

Keyphrases

• Optimal Selection 100%
• Natural Killer Cells 100%
• NKG2A 100%
• Myeloma 100%
• HLA-E 100%
• Myeloma Cells 71%
• HLA Class I 42%
• KIR Ligand 28%
• KIR2DL2 28%
• Clinical Application 14%
• Therapeutic Perspectives 14%
• Low Expression 14%
• Inhibitory Receptors 14%
• Bone Marrow 14%
• Natural Killer 14%
• Interleukin-2 14%
• Clinical Efficacy 14%
• Oxygen Level 14%
• Low Oxygen 14%
• Bone Marrow Niche 14%
• Multiple Myeloma Patients 14%
• Patient-derived 14%
• Degranulation 14%
• RAG2 14%
• Natural Killer Cell Therapy 14%
• U266 Cells 14%
• Natural Killer Cell Degranulation 14%
• Concurrent Analysis 14%
• KIR3DL1 14%

INIS

• natural killer cells 100%
• levels 28%
• patients 28%
• in vivo 28%
• in vitro 28%
• ligands 28%
• bone marrow 28%
• reactivity 14%
• therapy 14%
• applications 14%
• receptors 14%
• mice 14%
• oxygen 14%
• inhibition 14%
• evaluation 14%
• growth 14%
• surfaces 14%
• immunotherapy 14%
• infusion 14%

Immunology and Microbiology

• Natural Killer Cell 100%
• Myeloma Cell 57%
• Degranulation 28%
• Cell Line 14%
• Interleukin 2 14%
• Multiple Myeloma 14%
• Coculture 14%
• Immunotherapy 14%
• Myeloma Cell Line 14%
• Killer Cell Immunoglobulin Like Receptor 2DL1 14%
• KIR3DL1 14%